Olivier Loeillot
President, CEO & DirectorMr. Olivier Loeillot is President of Repligen Corporation from October 02, 2023 & served as it's Chief Commercial Officer and serves as it's CEO & Director since September 1, 2024. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE Healthcare Life Sciences. In his most recent role at Cytiva, he served as Bioprocess President from 2018 to 2022, overseeing the overall Bioprocess portfolio from cell culture media to purification resins and including process equipment, single-use technologies and enterprise solutions. Prior to Cytiva, he worked for a combined 12 years with Lonza, advancing to Vice President Sales, Lonza Custom Manufacturing. Mr. Loeillot joins Repligen as Chief Executive Officer (CEO) of Ascensus Specialties. During his tenure at Cytiva and prior to being named Bioprocess President in 2018, Mr. Loeillot was instrumental in building and leading the Enterprise Solutions business, managing the Bioprocess ASIA business in Singapore and directing the Genomics and Cellular Research division. During his time at Lonza AG he served as Vice President of Sales for the companys Custom Manufacturing Business (Basel) after leading the Microbial Biopharmaceuticals group (Basel). Mr. Loeillot earned his Masters degree in Chemistry in 1993 from the European High Institute of Chemistry (EHICS) of Strasbourg, France and later completed a Masters of Business Administration (MBA) program at CESMA Business School of EM Lyon.
Positions
- Company NameRepligen CorporationStock CodeRGENPositionPresident, CEO & DirectorColleagues
- MDMartin D. MadausIndependent Chair of the Board
- JKJason K. GarlandCFO & Chief Compliance Officer
- JRJames R. BylundChief Operating Officer
- AJAnthony J. HuntAdvisor
- RKRalf KuriyelSenior Vice President of Research & Development
- GPGlenn P. MuirIndependent Director
- MAMargaret A. PaxIndependent Director
- NMNicholas M. BarthelemyIndependent Director
